Rights and permissions
About this article
Cite this article
NZ drug subsidy agency must look beyond statin prices. Pharmacoecon. Outcomes News 180, 3 (1998). https://doi.org/10.1007/BF03277743
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03277743